Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY) is a multinational pharmaceutical company that specializes in developing, manufacturing, and marketing prescription drugs and biologic products. The company has a diverse portfolio of products, including cancer and cardiovascular disease treatments. BMS is headquartered in New York City and operates globally, with a strong presence in both developed and emerging markets.
Company Info
| ISIN | US1101221083 |
|---|---|
| CUSIP | 110122108 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Highlights
| Market Cap | $100.34B |
|---|---|
| EPS (TTM) | -$3.25 |
| PEG Ratio | 2.30 |
| Total Revenue (TTM) | $46.51B |
| Gross Profit (TTM) | $32.93B |
| EBITDA (TTM) | $17.96B |
| Year Range | $39.04 - $56.66 |
| Target Price | $46.47 |
| Short % | 1.10% |
| Short Ratio | 1.81 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BMY vs. MRK, BMY vs. GILD, BMY vs. MDT, BMY vs. UNH, BMY vs. ABBV, BMY vs. SCHD, BMY vs. LLY, BMY vs. VTI, BMY vs. T, BMY vs. VONG
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Bristol-Myers Squibb Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Bristol-Myers Squibb Company had a return of 0.21% year-to-date (YTD) and -11.34% in the last 12 months. Over the past 10 years, Bristol-Myers Squibb Company had an annualized return of 2.71%, while the S&P 500 had an annualized return of 10.88%, indicating that Bristol-Myers Squibb Company did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 0.21% | 18.13% |
| 1 month | 0.26% | 1.45% |
| 6 months | -1.88% | 8.81% |
| 1 year | -11.34% | 26.52% |
| 5 years (annualized) | 3.31% | 13.43% |
| 10 years (annualized) | 2.71% | 10.88% |
Monthly Returns
The table below presents the monthly returns of BMY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3.65% | 3.85% | 6.86% | -18.03% | -6.49% | 1.07% | 16.26% | 5.03% | 0.21% | ||||
| 2023 | 1.77% | -5.08% | 0.51% | -2.87% | -3.49% | -0.76% | -1.89% | -0.87% | -5.86% | -10.32% | -4.17% | 3.91% | -26.14% |
| 2022 | 4.99% | 5.83% | 7.13% | 3.07% | 0.24% | 2.76% | -4.18% | -8.63% | 5.46% | 9.80% | 3.63% | -10.38% | 18.98% |
| 2021 | -0.97% | -0.16% | 3.74% | -1.12% | 5.29% | 1.67% | 2.32% | -1.49% | -10.78% | -1.30% | -8.17% | 16.26% | 2.88% |
| 2020 | -1.24% | -6.18% | -5.62% | 10.00% | -1.79% | -1.54% | 0.52% | 6.03% | -3.07% | -2.32% | 6.76% | 0.20% | 0.41% |
| 2019 | -4.27% | 4.64% | -7.65% | -1.82% | -2.28% | -0.04% | -1.21% | 8.24% | 5.49% | 14.08% | -0.75% | 12.73% | 27.74% |
| 2018 | 2.82% | 5.75% | -4.46% | -17.05% | 0.94% | 5.17% | 6.93% | 3.06% | 2.53% | -18.07% | 5.78% | -2.77% | -12.90% |
| 2017 | -15.32% | 15.36% | -4.11% | 3.82% | -3.75% | 3.28% | 2.83% | 6.29% | 5.39% | -2.68% | 2.48% | -3.02% | 7.71% |
| 2016 | -9.64% | -0.37% | 3.76% | 12.99% | -0.67% | 3.12% | 1.71% | -23.29% | -6.05% | -4.93% | 10.86% | 3.54% | -13.49% |
| 2015 | 2.10% | 1.08% | 5.88% | -0.62% | 1.37% | 3.00% | -0.80% | -9.40% | 0.17% | 11.40% | 1.61% | 3.22% | 19.26% |
| 2014 | -5.98% | 7.60% | -3.39% | -2.91% | -0.70% | -2.47% | 5.13% | 0.06% | 1.05% | 14.50% | 1.48% | 0.59% | 14.18% |
| 2013 | 12.10% | 2.30% | 11.41% | -2.75% | 15.84% | -2.87% | -2.48% | -3.58% | 11.01% | 14.33% | -2.17% | 4.15% | 69.96% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BMY is 27, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Bristol-Myers Squibb Company granted a 4.79% dividend yield in the last twelve months. The annual payout for that period amounted to $2.37 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.37 | $2.28 | $2.16 | $1.47 | $2.29 | $1.64 | $1.60 | $1.56 | $1.14 | $1.49 | $1.45 | $1.76 |
Dividend yield | 4.79% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Monthly Dividends
The table displays the monthly dividend distributions for Bristol-Myers Squibb Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $1.80 | |||
| 2023 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $2.28 |
| 2022 | $0.54 | $0.00 | $0.54 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $2.16 |
| 2021 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.00 | $0.49 | $0.00 | $0.49 | $0.00 | $0.00 | $0.00 | $1.47 |
| 2020 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.49 | $2.29 |
| 2019 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $1.64 |
| 2018 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $1.60 |
| 2017 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $1.56 |
| 2016 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $1.14 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.37 | $0.00 | $0.37 | $0.00 | $0.00 | $0.38 | $1.49 |
| 2014 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.37 | $1.45 |
| 2013 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.36 | $1.76 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Bristol-Myers Squibb Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bristol-Myers Squibb Company was 70.62%, occurring on Jul 24, 2002. Recovery took 2721 trading sessions.
The current Bristol-Myers Squibb Company drawdown is 34.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -70.62% | Oct 29, 1999 | 685 | Jul 24, 2002 | 2721 | May 15, 2013 | 3406 |
| -53.71% | Aug 11, 1972 | 538 | Oct 1, 1974 | 184 | Jun 24, 1975 | 722 |
| -47.67% | Dec 5, 2022 | 396 | Jul 3, 2024 | — | — | — |
| -39.3% | Jul 15, 2016 | 759 | Jul 22, 2019 | 462 | May 20, 2021 | 1221 |
| -38.47% | Jan 10, 1992 | 403 | Aug 12, 1993 | 541 | Oct 3, 1995 | 944 |
Volatility
Volatility Chart
The current Bristol-Myers Squibb Company volatility is 5.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Bristol-Myers Squibb Company.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |